Financial Constraints to Molecular Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. David Rimm and Roy Herbst discuss the challenges of reimbursement by payers and the costs to pathology department of molecular biomarker testing, especially immunohistochemistry and DNA testing.
Linda Bosserman provides an overview of the nuances of personalized medicine as it relates to cost, value and access
Dr Wainberg and Dr Gerson identify some of the challenges of preclinical models versus clinical trials.